Invention Grant
- Patent Title: Deuterated pyrazino[2,1-a]isoquinoline compounds and methods of treatment using the same
-
Application No.: US14958461Application Date: 2015-12-03
-
Publication No.: US09944635B2Publication Date: 2018-04-17
- Inventor: Julie F. Liu , Scott L. Harbeson , Roger D. Tung
- Applicant: Concert Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee: Concert Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Wei Song
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07B59/00 ; A61K31/4184 ; A61K31/4985
![Deuterated pyrazino[2,1-a]isoquinoline compounds and methods of treatment using the same](/abs-image/US/2018/04/17/US09944635B2/abs.jpg.150x150.jpg)
Abstract:
This invention in one embodiment is directed to a compound of Formula Ia; where the designation (R) indicates that the designated carbon has the (R) stereochemistry; and wherein Z1 is hydrogen or fluorine; Z2 is hydrogen, deuterium, or fluorine; Z3 is deuterium; Z4 is fluorine; m is an integer from 0 to 10; n is an integer from 0 to 2; provided that: the sum of m+n does not exceed 10; and when both Z1 and Z2 are hydrogen, the sum of m+n is greater than 0, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are beneficially treated by administering an antihelminthic agent, such as praziquantel.
Public/Granted literature
- US20160083385A1 PYRAZINOISOQUINOLINE COMPOUNDS Public/Granted day:2016-03-24
Information query